SEA Medical: Technology to Prevent Deadly IV Mistakes
Intravenous (IV) drugs leave a huge margin for human error, particularly at the point of administration.
Month: February 2010
Defining a Radiation Target with Augmenix
The company’s SpaceOAR System is designed to temporarily separate organs during radiotherapy so that normal tissues are spared, and to mark tumor resection sites to allow for targeted therapy.
Streamlining the Stenting Process with Svelte Medical
The company’s first product is a low-profile “Stent-On-a-Wire” system that reduces the number of steps involved in the stenting procedure.
IN3 West Is Almost Here
Register now to attend IN3 West, which takes place March 3-5 at the Venetian Hotel-Resort-Casino in Las Vegas.
Nabi Tries to Help Smokers Break the Habit
“Quitting smoking” is one of the most popular New Year’s resolutions, right up there with “losing weight” and “exercising more.”
Access Pharma (ACCP.OB) Product Development Update – Sponsored Post
Access Pharmaceuticals (OTC: ACCP.OB, “Access”) develops and commercializes products for the treatment and supportive care of cancer patients.
A Busy Year for HydraDx
The economy is tough for biotech start-ups, but the CEO of HydraDx is feeling confident.
Dimera Fights the “Silent Killer”
According to the American Heart Association, heart disease is the number one killer of women over age 25–more than the next five causes of death, or all forms of cancer, combined.
Less-Invasive Spinal Surgery with Trinity Orthopedics
The San Diego-based company aims to reduce the incidence of complications resulting from lumbar spinal surgery, such as nerve damage or degeneration of adjacent discs.
Ovatech Leaves the Hormones Out of Birth Control
Ovatech of Auburndale, Mass., is developing the world’s first non-hormonal, female-controlled contraception device.